Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1.

Autor: Yasuda, Ken‐ichi, Nobeyama, Yoshimasa, Ishiji, Takaoki, Ota, Arihito, Asahina, Akihiko
Předmět:
Zdroj: Clinical Case Reports; Nov2020, Vol. 8 Issue 11, p2125-2128, 4p
Abstrakt: Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje